Baylor College of Medicine: Wnt Signaling is Identified as a Target in Neurodevelopmental Disorder With Regression, Abnormal Movements, Loss of Speech, and Seizures Disorder
February 01, 2022
February 01, 2022
HOUSTON, Texas, Feb. 1 (TNSJou) -- The Baylor College of Medicine issued the following news on Jan. 31, 2022:
A recent study conducted by researchers at Baylor College of Medicine and Texas Children's Hospital is the first to identify an underlying mechanism and possible drug targets for a new severe neurological disorder in children called NEDAMSS. The researchers report their findings in the journal Science Advances.
The disorder, called NEDAMSS for neurodevelopm . . .
A recent study conducted by researchers at Baylor College of Medicine and Texas Children's Hospital is the first to identify an underlying mechanism and possible drug targets for a new severe neurological disorder in children called NEDAMSS. The researchers report their findings in the journal Science Advances.
The disorder, called NEDAMSS for neurodevelopm . . .